Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
Kyung Kee Baek, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
Cancer Res Treat. 2010;42(4):185-190.   Published online 2010 Dec 31     DOI: https://doi.org/10.4143/crt.2010.42.4.185
Citations to this article as recorded by Crossref logo
Efficacy and safety of traditional plant-based medicines for preventing chronic oxaliplatin-induced peripheral neurotoxicity in patients with colorectal cancer: A systematic review and meta-analysis with core herb contribution
Jierong Han, Hengzhou Lai, Wenyuan Li, Huarui Liao, Chong Xiao, Xueke Li, Fengming You, Jing Guo
Journal of Ethnopharmacology.2024; 326: 117735.     CrossRef
Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment
Zhe Li, Xin Qiao, Xiao-Meng Liu, Shu-Hao Shi, Xin Qiao, Jing-Yuan Xu
European Journal of Medicinal Chemistry.2023; 250: 115233.     CrossRef
Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
Yu Mei, Xijia Feng, Tienan Feng, Min Yan, Zhenggang Zhu, Tian Li, Zhenglun Zhu
Frontiers in Pharmacology.2022;[Epub]     CrossRef
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
Roser Velasco, Montserrat Alemany, Macarena Villagrán, Andreas A. Argyriou
Journal of Personalized Medicine.2021; 11(7): 669.     CrossRef
The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey
Nadeen T Ali, Amel A Mohamed, Bashir A Yousef
Asia-Pacific Journal of Oncology Nursing.2020; 7(3): 266.     CrossRef
Clinical pharmacology of oncology agents in older adults: A comprehensive review of how chronologic and functional age can influence treatment-related effects
Ginah Nightingale, Rowena Schwartz, Ekaterina Kachur, Brianne N. Dixon, Christine Cote, Ashley Barlow, Brooke Barlow, Patrick Medina
Journal of Geriatric Oncology.2019; 10(1): 4.     CrossRef
Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
Se Hoon Park, Jeeyun Lee, Tae Sung Sohn, Do Hoon Lim, Kyoung-Mee Kim, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Su Jin Lee, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
Precision and Future Medicine.2019; 3(1): 24.     CrossRef
Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15
Rachel M McQuade, Vanesa Stojanovska, Rhian Stavely, Cara Timpani, Aaron C Petersen, Raquel Abalo, Joel C Bornstein, Emma Rybalka, Kulmira Nurgali
British Journal of Pharmacology.2018; 175(4): 656.     CrossRef
Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients
Akie Watanabe, Chang Cheng Yang, Winson Y. Cheung
Medical Oncology.2018;[Epub]     CrossRef
Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin‐induced peripheral neuropathy in Taiwanese patients with colorectal cancer
Shu‐Yi Hsu, Wen‐Shih Huang, Shu‐Hui Lee, Tsui‐Ping Chu, Yung‐Chang Lin, Chang‐Hsien Lu, Randal D. Beaton, Sui‐Whi Jane
European Journal of Cancer Care.2018; : e12976.     CrossRef
Factors associated with the development and severity of oxaliplatin‐induced peripheral neuropathy: a systematic review
Jeremy N. Pulvers, Gavin Marx
Asia-Pacific Journal of Clinical Oncology.2017; 13(6): 345.     CrossRef
Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy
Kelly A Aromolaran, Peter A Goldstein
Molecular Pain.2017; 13: 174480691771469.     CrossRef
ALA-induced photodynamic effect on vitality, apoptosis, and secretion of vascular endothelial growth factor (VEGF) by colon cancer cells in normoxic environment in vitro
A. Kawczyk-Krupka, K. Sieroń-Stołtny, W. Latos, Z.P. Czuba, B. Kwiatek, M. Potempa, K. Wasilewska, W. Król, A. Stanek
Photodiagnosis and Photodynamic Therapy.2016; 13: 308.     CrossRef
ALA-induced photodynamic effect on viability, apoptosis and secretion of S100 protein, secreted by colon cancer cells in vitro
Aleksandra Kawczyk-Krupka, Wojciech Latos, Magdalena Latos, Zenon P. Czuba, Aleksander Sieroń
Photodiagnosis and Photodynamic Therapy.2016; 15: 218.     CrossRef
ALA-mediated photodynamic effect on apoptosis induction and secretion of macrophage migration inhibitory factor (MIF) and of monocyte chemotactic protein (MCP-1) by colon cancer cells in normoxia and in hypoxia-like conditions in vitro
Aleksandra Kawczyk-Krupka, Andrzej M. Bugaj, Wojciech Latos, Katarzyna Wawrzyniec, Piotr Oleś, Anna Mertas, Zenon Czuba, Wojciech Król, Karolina Sieroń-Stołtny, Aleksander Sieroń
Photodiagnosis and Photodynamic Therapy.2015; 12(1): 27.     CrossRef
The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy
Joanna E. Fardell, Janette Vardy, Lauren A. Monds, Ian N. Johnston
Behavioural Brain Research.2015; 291: 80.     CrossRef
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
Andreas Argyriou
Toxics.2015; 3(2): 187.     CrossRef
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity
Lorenzo Di Cesare Mannelli, Barbara Tenci, Matteo Zanardelli, Paola Failli, Carla Ghelardini
Neural Plasticity.2015; 2015: 1.     CrossRef
Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran
Ali Shahriari-Ahmadi, Ali Fahimi, Mehrdad Payandeh, Masoud Sadeghi
Asian Pacific Journal of Cancer Prevention.2015; 16(17): 7603.     CrossRef
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
R. Velasco, J. Bruna, C. Briani, A. A. Argyriou, G. Cavaletti, P. Alberti, B. Frigeni, M. Cacciavillani, S. Lonardi, D. Cortinovis, M. Cazzaniga, C. Santos, H. P. Kalofonos
Journal of Neurology, Neurosurgery & Psychiatry.2014; 85(4): 392.     CrossRef
Chemotherapy-induced neuropathy: A comprehensive survey
N.C. Miltenburg, W. Boogerd
Cancer Treatment Reviews.2014; 40(7): 872.     CrossRef
Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study
A. Custodio, J. Moreno-Rubio, J. Aparicio, J. Gallego-Plazas, R. Yaya, J. Maurel, O. Higuera, E. Burgos, D. Ramos, A. Calatrava, E. Andrada, R. López, V. Moreno, R. Madero, P. Cejas, J. Feliu
Annals of Oncology.2014; 25(2): 398.     CrossRef
Oxaliplatin Neurotoxicity
Roser Velasco, Jordi Bruna
Current Colorectal Cancer Reports.2014; 10(3): 303.     CrossRef
Anti-Colorectal Cancer Chemotherapy-Induced Diarrhoea: Current Treatments and Side-Effects
Rachel M. McQuade, Joel C. Bornstein, Kulmira Nurgali
International Journal of Clinical Medicine.2014; 05(07): 393.     CrossRef
Oxaliplatin Induced Neurotoxicity among Patients with Colorectal Cancer: Documentation in Medical Records—A Pilot Study
Jenny E. Drott, Hans Starkhammar, Sussanne Börjeson, Carina M. Berterö
Open Journal of Nursing.2014; 04(04): 265.     CrossRef
Advanced age and liability to oxaliplatin‐induced peripheral neuropathy: post hoc analysis of a prospective study
A. A. Argyriou, C. Briani, G. Cavaletti, J. Bruna, P. Alberti, R. Velasco, S. Lonardi, D. Cortinovis, M. Cazzaniga, M. Campagnolo, C. Santos, H. P. Kalofonos
European Journal of Neurology.2013; 20(5): 788.     CrossRef
Neuropatia Periférica em Pacientes com Câncer Colorretal em Tratamento com Oxaliplatina
Helena Maria de Cerqueira Mathias, Maria Cecília Mathias Machado, Adriano Celso Rodrigues
Revista Neurociências.2013; 21(3): 435.     CrossRef
Polymorphic markers associated with severe oxaliplatin‐induced, chronic peripheral neuropathy in colon cancer patients
Hong‐Hee Won, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Jong‐Won Kim, Soo‐Youn Lee, Se Hoon Park
Cancer.2012; 118(11): 2828.     CrossRef
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
A.A. Argyriou, R. Velasco, C. Briani, G. Cavaletti, J. Bruna, P. Alberti, M. Cacciavillani, S. Lonardi, C. Santos, D. Cortinovis, M. Cazzaniga, H.P. Kalofonos
Annals of Oncology.2012; 23(12): 3116.     CrossRef
Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial
R. X. Zhang, Z. H. Lu, D. S. Wan, X. J. Wu, P. R. Ding, L. H. Kong, Z. Z. Pan, G. Chen
International Journal of Colorectal Disease.2012; 27(12): 1645.     CrossRef